Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas systems provide protection against viral 1 and plasmid 2 infection by capturing short DNA sequences from these invaders and integrating them into the CRISPR locus of the prokaryotic host 1 . These sequences, known as spacers, are transcribed into short CRISPR RNA guides 3-5 that specify the cleavage site of Cas nucleases in the genome of the invader 6-8 . It is not known when spacer sequences are acquired during viral infection. Here, to investigate this, we tracked spacer acquisition in Staphylococcus aureus cells harbouring a type II CRISPR-Cas9 system after infection with the staphylococcal bacteriophage φ12. We found that new spacers were acquired immediately after infection preferentially from the cos site, the viral free DNA end that is first injected into the cell. Analysis of spacer acquisition after infection with mutant phages demonstrated that most spacers are acquired during DNA injection, but not during other stages of the viral cycle that produce free DNA ends, such as DNA replication or packaging. Finally, we showed that spacers acquired from early-injected genomic regions, which direct Cas9 cleavage of the viral DNA immediately after infection, provide better immunity than spacers acquired from late-injected regions. Our results reveal that CRISPR-Cas systems exploit the phage life cycle to generate a pattern of spacer acquisition that ensures a successful CRISPR immune response.
from the type II-A CRISPR locus and left only a single repeat sequence. We also used a cas9 allele, hyper-cas9 or hcas9, which enhances spacer acquisition by two orders of magnitude 17 . Using this system and a PCR amplification technique that enriches for newly incorporated spacers (Extended Data Fig. 1a ), we were able to detect rare spacer acquisition events occurring minutes after phage infection. We first looked at the autoimmunity pattern of chromosomal spacer acquisition during exponential growth. The PCR products of adapted CRISPR loci were subjected to next-generation sequencing and the reads per million (RPM) for each new spacer sequence were calculated (full data for all next generation sequencing experiments in this manuscript are provided in Supplementary Data File 1; a summary of these data in table format is provided in Supplementary Data File 2). Plotting the RPM values for spacers of chromosomal origin along the S. aureus genome revealed a strong adaptation hotspot surrounding the dif site, which marks the terminus of the circular bacterial chromosome ( Fig. 1a and Extended Data Fig. 1b-e ). The peak is limited by the first staphylococcal chi sequence (5′ -GAAGCGG-3′ ) 18 upstream from the dif site on each DNA strand (Extended Data Fig. 1b-e ). In addition, the introduction of an I-sceI site 19 resulted in an additional adaptation hotspot when the I-SceI endonuclease was expressed, again limited by chi sites (Fig. 1a and Extended Data Fig. 1f, g) . These results demonstrate that both type I and type II CRISPR-Cas systems can use free DNA ends resulting from DSBs as the source of new spacers for CRISPR adaptation.
Are free DNA ends also used for spacer acquisition during the CRISPR-Cas immune response against viral infection? If so, when during the life cycle of the invading virus are these free DNA ends generated? Free DNA ends can be found during several stages of the infectious cycle of lambda-like dsDNA (double-stranded DNA) bacteriophages, for example following DNA injection, through accidental DNA breaks during theta replication, following the transition to rolling-circle replication and throughout DNA packaging 20 . To address this fundamental question, we analysed the incorporation of new spacers shortly after infection with the lambda-like φ 12γ 3 bacteriophage (Extended Data Fig. 2a, b) , a lytic derivative of the temperate dsDNA staphylococcal phage φ 12 (ref. 21) . We first estimated the onset of φ 12γ 3 lysis at approximately 45 min (Extended Data Fig. 2c ); therefore, we chose to analyse spacer acquisition 30 min after infection, when most phages are still going through the first lytic cycle. In doing so, we avoided the selection and counter-selection of spacer sequences that produce more or less efficient crRNAs, respectively, that occurs during multiple rounds of infection, and which could skew the original distribution of newly acquired spacers. In contrast to the acquisition of chromosomal spacer sequences (where the CRISPR adaptation hotspot was flanked by two symmetrically opposed chi sites), the majority of newly acquired viral spacers mapped to a 13-kb region (the φ 12 genome encompasses 45 kb) flanked by the cos site and its first upstream chi site, in experiments with a multiplicity of infection (MOI) of either 10 ( Fig. 1b ) or 1 (Extended Data Fig. 3a ). The cos site marks the viral free DNA ends that are generated by staggered cleavage of the phage DNA during packaging, which serve as cohesive ends for re-circularization of the linear phage genome after DNA injection 22 (Extended Data Fig. 2d, e ). The cos-adjacent pattern of spacer acquisition was not introduced by the enrichment primers or the use of the hcas9 allele (Extended Data Fig. 4 ), was observed on both DNA strands upstream from the cos site (Extended Data Fig. 5a -c) and was not simply a reflection of the PAM sequence distribution on the phage genome (Extended Data Fig. 5d , e). Efficient spacer acquisition depended on the AddAB repair machinery, the Gram-positive functional paralogue of RecBCD 11 , because S. aureus hosts harbouring a mutation in the nuclease active site of the AddA subunit (addA n ) showed a significant reduction in spacer acquisition with a small peak clustering close to the cos site but not reaching the first chi site ( Fig. 1b and Extended Data Fig. 3b , c). In addition, the introduction of two extra chi sites, approximately 2.5 kb upstream of the φ 12γ 3 cos site, created a new limit for the spacer acquisition hotspot, with a peak occurring immediately adjacent to the cos site (Extended Data Fig. 3d ). Together these results demonstrate that CRISPR adaptation against φ 12γ 3 exploits the presence of a natural and invariable free DNA end at the cos site of the virus to generate new spacers.
The results shown in Fig. 1b suggest that new spacers could be acquired soon after the injection of the viral DNA. It is also possible that spacer acquisition occurs during cos site cleavage at the initiation of genome packaging by terminase enzymes 23 or, similarly to the case of chromosomal spacer acquisition near the genome terminus, DSBs generated during viral DNA replication could be substrates for CRISPR adaptation (Extended Data Fig. 6a ). To distinguish between these possibilities, we measured spacer acquisition in φ 12 mutants impaired at different stages of the lytic cycle (Extended Data Fig. 6a-d ). polA mutant phages lack DNA polymerase A and therefore cannot replicate the injected genome ( Fig. 2a ). Additionally, they cannot continue the lytic cycle after injection and produce neither intracellular ( Fig. 2b ) nor extracellular viral particles ( Fig. 2c ). Therefore these mutants provide a measure of the level of spacer acquisition that occurs after injection and before replication (Extended Data Fig. 6a, b ). terS mutants lack the small subunit of the terminase complex and are incapable of cos site cleavage by this complex during DNA packaging 23 . After DNA injection they can replicate their genome ( Fig. 2a ) but cannot form either functional intracellular ( Fig. 2b ) or extracellular viral particles ( Fig. 2c ). Thus, spacer acquisition in the terS mutants can occur during DNA injection and replication but before DNA packaging (Extended Data Fig. 6a, b ). Finally, phages with a deletion encompassing the genes encoding the holin and lysin enzymes (ho/ly) are impaired at host lysis 24 , but can replicate ( Fig. 2a ) and package their DNA, producing intracellular ( Fig. 2b ) but not extracellular ( Fig. 2c ) viral particles. In this mutant, spacer acquisition can occur throughout DNA injection, replication and packaging, but not during a second infectious cycle (Extended Data Fig. 6a, b ). First, we compared adaptation levels between terS and ho/ly mutants 0 and 60 min after infection, when DNA packaging is mostly completed in the ho/ly mutant (Fig. 2b) . We did not detect significant differences in spacer incorporation between these two infections, either quantitatively ( Fig. 2d ) or qualitatively (Extended Data Fig. 6f ), demonstrating that the free DNA ends generated at the cos site during phage DNA packaging do not contribute substantially to the generation of new spacers. To measure how much CRISPR adaptation occurs during phage DNA replication, we compared the levels of spacer acquisition between polA and ho/ly mutants 0 and 30 min after infection, when DNA levels in the ho/ly mutant are approximately 30-fold higher than in the polA mutant ( Fig. 2a ). Both mutants allowed similar spacer incorporation into the CRISPR array, both quantitatively ( Fig. 2e ) and qualitatively (Extended Data Fig. 6e ), demonstrating that replication is not a major stage in the viral cycle for the acquisition of new spacers. These results suggest that the great majority of new spacers are acquired early in the phage life cycle, during or shortly after injection of the viral dsDNA ends. In addition, because the phage mutants cannot propagate, these results show that the pattern of spacer acquisition is not a result of selection generated by multiple infection cycles. This suggests that adaptation rates should align with the MOI, which directly determines how many phage dsDNA ends are injected. We found that adaptation rates were linearly correlated with the MOI (Extended Data Fig. 6g ). Additionally, the region of the phage genome that is first injected into the host would be expected to be the source of most of the new spacers. To test this prediction, we inverted the cos site (116 base pairs) of φ 12γ 3, generating φ 12γ 3 cos-flip (Fig. 2f ), a phage with an inverted order of entry. In contrast to the pattern of CRISPR adaptation obtained after exposure to wild-type phages, during infection with the mutant phage, a minority of spacers were acquired from the region upstream of the cos site, with the highest spacer density mapping occurring downstream of the flipped cos site at MOIs of both 10 ( Fig. 2g ) and 1 (Extended Data Fig. 3a ). Acquisition peaks in φ12γ3 cos-flip were lower but covered a larger area than those in φ12γ3; this is probably because there are no chi sites in the reverse strand of the φ 12 genome to limit and concentrate adaptation activity. Accordingly, spacer acquisition from φ 12γ 3 cos-flip in the addA n mutant displayed a major peak within 5 kb of the cos site, a mirror image pattern of that observed for φ 12γ 3 (Extended Data Fig. 3e ). Together, the data in Fig. 2 demonstrate that the acquisition of spacer sequences by the CRISPR-Cas adaptation machinery occurs primarily from the viral dsDNA ends that are first introduced during the injection of the φ 12γ 3 genome. This pattern of spacer acquisition presents a potential advantage to the immunized host population upon subsequent phage encounters, as the cos-adjacent spacers will direct the Cas9 nuclease to cleave the next invading virus shortly after its injection. To test this idea, we generated a library of spacers that were evenly distributed throughout the φ 12γ 3 genome ( Fig. 3a and Extended Data Fig. 7a-f ). Cells harbouring these spacers were infected with φ 12γ 3 or φ 12γ 3 cos-flip phages in conditions in which the incorporation of additional spacers is inhibited (Extended Data Fig. 7c, d ). Staphylococci that survived infection overnight were collected and their spacer content was assessed by next-generation sequencing to determine whether the selective pressure of the phage caused enrichment for spacers targeting any particular region of φ 12γ 3. Spacers targeting the region immediately upstream of the cos site-the region that is injected first-were enriched after infection with wild-type φ 12γ 3 ( Fig. 3a and Extended Data Fig. 7g ). The opposite pattern was observed following φ 12γ 3 cos-flip infection, with the enrichment of spacers targeting the region that is downstream of the flipped cos site ( Fig. 3a and Extended Data Fig. 7g ). This pattern of selection, which was opposite for spacers targeting different sides of the cos site, is more evident when spacer enrichment is plotted as the ratio of φ 12γ 3/φ 12γ 3 cos-flip RPMs (Fig. 3b and Extended Data Fig. 7h ). These results suggest that during the targeting phase of CRISPR-Cas immunity, Cas9 cleavage of early-injected phage sequences provides better phage clearance than the cleavage of late-injected sequences. To corroborate this, we used a type II CRISPR-Cas system programmed with spacers targeting viral sequences immediately (within 1 kb) upstream or downstream of the cos site ( Fig. 3c ). During infection with wild-type φ 12γ 3, the three upstream spacers target the first region to be injected; during infection with φ 12γ 3 cos-flip , the order of targeting is inverted (Fig. 3c ). In host populations in which all bacteria carry one of these six spacer sequences, CRISPR-Cas immunity allows cells to survive upon infection with either of the two phages at a low MOI (Extended Data Fig. 8 ). However, the incorporation of new spacers during CRISPR immunization is a very rare event 1, 12 . To mimic this situation, we mixed bacteria programmed with either the three upstream or downstream spacers with staphylococci lacking a CRISPR-Cas plasmid at a ratio of 1:10,000 (ref. 25) , resulting in extremely high MOIs following the lysis of non-CRISPR cells. We then infected the mixed cultures with either φ 12γ 3 or φ 12γ 3 cos-flip . The population harbouring the three upstream targeting spacers was able to recover and survive infection with both φ 12γ 3 and φ 12γ 3 cos-flip , but recovery was delayed with the latter (Fig. 3d) . By contrast, the culture carrying the three downstream targeting spacers recovered rapidly and survived infection with φ 12γ 3 cos-flip but Letter reSeArCH not φ 12γ 3 (Fig. 3e) . These data confirm that the target location can strongly influence the efficiency of Cas9 targeting, especially immediately after CRISPR adaptation, when only a small fraction of cells acquire a new spacer. Together, our results demonstrate that spacer acquisition from early-injected viral sequences is an effective strategy for establishing a robust CRISPR-Cas immune response.
Our study showed that type II CRISPR-Cas systems use free DNA ends as an entry point for the acquisition of new spacers. During infection by dsDNA phages, the linear genomic end is injected first. We demonstrated that this initial step in viral infection is exploited by the CRISPR-Cas immune response both to acquire new anti-viral spacers and to direct Cas nucleases to the invading target rapidly after infection begins, immediately halting the lytic cycle (Extended Data Fig. 9 ). In addition, the preference for free DNA ends could provide a mechanism to prioritize the acquisition of spacers from the invading virus, which produces free DNA ends as an obligate life-cycle step, over the acquisition from chromosomal DNA (to avoid CRISPR autoimmunity). Our studies used the staphylococcal phage φ 12, whose DNA packaging mechanism ensures that every viral particle injects the cos site first (Extended Data Fig. 10a, b) . Analysis of the pattern of spacer acquisition after infection with the pac staphylococcal phage φ NM4γ 4, which lacks a defined genomic entry site, also shows a mode of spacer incorporation consistent with that seen in CRISPR adaptation during phage DNA injection (Extended Data Fig. 10c, d ), suggesting that our findings apply to both cos and pac dsDNA phages. We propose that, although not strictly required for spacer acquisition (Extended Data Fig. 3e ), DNA degradation by the AddAB helicase-nuclease of the injected viral genome (which starts at the cos site and ends at the first chi site) generates additional free DNA ends that are used as substrates for the Cas1-Cas2-Csn2-Cas9 spacer acquisition complex 12 to incorporate new viral sequences into the CRISPR array (Extended Data Fig. 9 ). We did not detect significant spacer acquisition in the opposite direction of the cos site (from the cos site DNA end that enters the cell last). This suggests that spacer acquisition occurs during DNA ejection. Notably, many dsDNA phages have evolved to protect their DNA ends from this degradation by producing proteins that cap the injected dsDNA end or inhibit degradation by RecBCD or AddAB 26 . It is plausible that the low frequency of spacer acquisition is related to these protection mechanisms, which would limit the generation of substrates for the Cas1-Cas2-Csn2-Cas9 complex. In this case, these mechanisms would provide protection for the phage against both RecBCD or AddAB degradation and CRISPR adaptation. Recent studies have shown that the injection of the phage lambda genome takes on average 5 min and can last for up to 20 min 27 ; this provides a window of opportunity for spacer acquisition before DNA injection is complete. It also allows cleavage of the viral DNA before it is completely ejected, which we have found to be important for an effective type II CRISPR-Cas immune response. Finally, CRISPR-Cas systems also acquire spacers from conjugative plasmids 2 , most of which transfer to neighbouring cells as ssDNA. Since ssDNA is not a good substrate for RecBCD 28 , it is unlikely that spacer acquisition happens during plasmid transfer; rather, it is likely to occur during plasmid replication, as reported previously 10 . In conclusion, our study highlights the close relationship between both stages of CRISPR-Cas immunity-immunization and targeting-and reveals how these immune systems have exploited the biology of phage infection to provide robust protection against prokaryotic predators.
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MethODS Bacterial strains and growth conditions. Cultivation of S. aureus RN4220 29 and E. coli strains were carried out in brain-heart infusion (BHI) medium or LB liquid medium (BD), respectively, at 37 °C, 30 °C for maintenance of pE194derived temperature-sensitive plasmids or 28 °C for maintenance of pIMAYbased plasmids. S. aureus medium was supplemented with chloramphenicol at 10 μ g ml −1 , erythromycin at 10 μ g ml −1 , kanamycin at 25 μ g ml −1 or spectinomycin at 250 μ g ml −1 . E. coli medium was supplemented with chloramphenicol at 25 μ g ml −1 , ampicillin at 100 μ g ml −1 , kanamycin at 50 μ g ml −1 or spectinomycin at 50 μ g ml −1 for plasmid maintenance. Media were supplemented with 1 mM IPTG (isopropyl β -d-1-thiogalactopyranoside) to express genes from the inducible promoters P spac and P spac(h) and with 2 μ g ml −1 mitomycin C (A&G Scientific) to induce prophage excision and propagation. PCR amplification of expanded CRISPR loci. CRISPR plasmids were harvested from S. aureus cells with a modified QIAprep Spin Miniprep Kit protocol: bacterial cell pellets were resuspended in 250 μ l P1 buffer supplemented with 107 μ g ml −1 lysostaphin (AMBI Products) and incubated at 37 °C for 10 min followed by the standard QIAprep protocol. We used 150 ng (log phase) or 50 ng (overnight) of plasmid as input for the enrichment PCR of the CRISPR locus using Phusion DNA Polymerase (Thermo) with the following primer mix: three parts JW8 or JW419 and one part each JW3, JW4 and JW5 (Supplementary Table 1 ). Variants of the primer JW8 with 3-8-bp bar codes at the 5′ end were used to distinguish experiments from each other during multiplexed high-throughput sequencing. PCRs with conventional primers were performed similarly using primers JW1131 and L401 with 5′ bar codes for multiplexing. Amplicons were gel-or PCR-purified and subjected to Illumina high-throughput sequencing with either the MiSeq, HiSeq or NextSeq platforms. Deep sequencing data analysis. Spacers were aligned to chromosomal, plasmid and phage genomes using the Burrows-Wheeler Aligner 30 . Perfectly aligned spacers were assigned to the position in the reference genome at the 5′ end of the alignment, and the number of spacers occurring at each genomic position was aggregated. Two layers of normalization were applied next. First, spacer counts were multiplied by a factor that accounted for the base at that spacer's 3′ end. The enrichment PCR leverages the clamping of the 3′ end (T, A or G) of the reverse primers with the 3′ ends of newly acquired spacers 12 . A reverse primer ending in C was omitted from the primer mix to avoid priming against the single repeat in non-adapted plasmids. Because of the increased G-C bond strength relative to A-T, spacers ending in C are overrepresented compared to spacers ending in A or T. Spacers ending in G, as well as non-adapted loci, are observed at low frequencies despite the absence of a perfectly matching reverse primer, which is likely to be due to 3′ trimming during primer synthesis or PCR. We therefore examined the observed frequencies of spacers ending in A, T, C or G following enrichment PCR and multiplied each by a factor that normalized the frequencies to the expected values of 22.8%, 41.9%, 18.1% and 17.2%. These values reflect the observed frequencies for phageor chromosome-derived spacers following amplification with non-enrichment primers (Extended Data Fig. 6a, b ). When using conventional primers, the spacer 3′ base normalization step was skipped. Following further aggregation of read counts into 1-kb (phage) or 10-kb (S. aureus chromosome) bins, we multiplied each bin by a factor accounting for the number of GG sequences within that bin, and on a given DNA strand where applicable. This was based on the observation that adaptation occurs primarily at sites immediately upstream of a 5′ -NGG-3′ sequence, known as the PAM 12 . Finally, RPM were calculated as RPM tot , RPM spc , RPM φ12 or RPM chr . RPM tot corresponds to phage reads within a bin per million total CRISPR loci (including adapted and unadapted sites), while RPM spc corresponds to phage reads per million total spacers (from chromosomal, plasmid and phage sequences). These are measures of absolute spacer acquisition rates, where RPM tot is used for comparisons across different host cell genetic backgrounds and RPM spc is used for comparisons within the same genetic background. RPM φ12 refers to phage reads within a bin per million total phage reads. RPM chr refers to chromosomal reads within a bin per million total chromosomal reads. RPM φ12 and RPM chr highlight the distribution of acquired spacers within a given genome. Phage construction. We used a variation of a previously described method 31 . φ 12γ 3 was isolated as a spontaneous escaper plaque following infection of φ 12 on a soft agar lawn of S. aureus RN4220 cells carrying plasmid pJW479, which encodes a type III CRISPR-Cas system targeting the φ 12 cI-like repressor. PCR of the cI locus confirmed that there was a 1,347-bp deletion spanning the complete cI gene and the first 616 base pairs of the upstream gene (RNaseT family protein), as indicated in Extended Data Fig. 2a. φ 12γ 3 cos-flip was created by propagating φ 12γ 3 in liquid culture in cells harbouring plasmid pJW481, which contains the flipped cos site, and surrounding upstream and downstream homology regions for recombination with the phage genome. Recombinant φ 12γ 3 cos-flip plaques were recovered on a soft agar lawn of RN4220 cells carrying plasmid pJW482, which encodes a type III CRISPR-Cas system targeting a sequence present only in φ 12γ 3 and not in φ 12γ 3 cos-flip . φ 12γ 3 chi-extra was created in a similar fashion to φ 12γ 3 cos-flip , where pJW484 and pJW483 were substituted for the recombination and targeting plasmid, respectively. Strain construction. The addA n (D1159A) nuclease domain mutation was introduced into the S. aureus RN4220 genome (generating strain JW418), using the pIMAY allelic replacement system 32 with plasmid pJW233. An I-sceI recognition site immediately adjacent to a kanamycin-resistance gene (for selection purposes) was introduced into the S. aureus RN4220 genome at the srtA locus (generating strain JW263), using the pMAD allelic replacement system 33 with plasmid pJW480. Mutations in φ 12 were introduced into strains of S. aureus RN4220 harbouring the φ 12 prophage, using the pWJ244/pWJ327 allelic replacement system developed in our laboratory by W.J. A pWJ244-derived suicide vector containing the ho/ly mutation was introduced by electroporation into S. aureus RN4220::φ 12 lysogens. Co-integrants (containing the plasmid integrated into the chromosome via recombination) were isolated on BHI agar plates supplemented with chloramphenicol and grown at 37 °C. pWJ327-derived temperature-sensitive plasmids containing the polA and terS mutations were introduced by electroporation into S. aureus RN4220::φ 12 lysogens and colonies were grown on plates supplemented with chloramphenicol at 28 °C. Co-integrants were isolated by re-streaking colonies from 28 °C plates directly onto 37 °C plates. Co-integrants of either pWJ244 or pWJ327 were re-struck onto a second chloramphenicol plate and grown at 37 °C to remove non-transformed, background cells and their genotype was confirmed by PCR using primers that amplify the integration site. Bona fide co-integrants were grown overnight in plain medium at 28 °C. Logarithmic-phase cultures were treated with the pWJ326 counter-selection phagemid, producing a Cas9 nuclease programmed to target and destroy the cat gene of the integrated plasmid for 1 h and plated on BHI agar supplemented with erythromycin at 30 °C. The selected mutants were confirmed by PCR and Sanger sequencing and by checking their growth on chloramphenicol plates at 37 °C (to ensure sensitivity to chloramphenicol). Mutants were re-struck at 30 °C on BHI agar supplemented with erythromycin, and colonies were inoculated overnight in plain BHI at 37 °C to inhibit replication of pWJ326 and to alleviate this counter-selection plasmid. Cultures were plated on plain BHI agar at 37 °C overnight, and colonies were replica-plated on both plain BHI agar at 37 °C and BHI agar supplemented with erythromycin at 30 °C to check for plasmid loss. With this method, strains JW924, JW833 and JW563, containing the polA, terS and ho/ly mutations, were created using plasmids pJW430, pJW410 and pJW271, respectively. pWJ326 phagemid propagation. S. aureus ST24 cells 34 harbouring plasmid pWJ326 were inoculated at 30 °C in BHI supplemented with erythromycin. Spontaneous induction of prophage 80α resulted in the exclusive phage packaging of pWJ326, which harbours the sequence for the 80α packaging (pac) site, within the 80α terS gene. pWJ326 phagemids were isolated by concentrating the supernatant of overnight S. aureus ST24/pWJ326 cultures using Amicon Ultra centrifugal filter units (EMD Millipore) and resuspending the retentate in one tenth of the original volume of PBS. Propagation of φ12 mutants. The φ 12 mutant lysogenic strains JW924, JW833 and JW563, harbouring the complementing plasmids pJW474, pJW383 and pJW278, respectively, were induced from logarithmic phase cultures by the simultaneous addition of 2 μ g ml −1 mitomycin C and 1 mM IPTG for 3 h. Supernatants were filtered through 0.45-μ m syringe filters (Acrodisc), concentrated with Amicon Ultra centrifugal filter units (EMD Millipore) and resuspended in PBS. In order to generate phage stocks that were free of mitomycin C-induced DNA damage, logarithmic phase cultures of S. aureus RN4220 harbouring the complementing plasmids pJW474, pJW383 and pJW278 were infected with the PBS phage stocks obtained from strains JW924, JW833 and JW563, respectively, at an MOI of 1 and treated with 1 mM IPTG. After 3 h, final phage stocks were prepared by filtration of the supernatant.
For the experiments in Fig. 2c -g, infections were performed at an approximate MOI of 10. Subsequently, the precise MOI was determined for each experiment, and the qPCR data and adaptation bar graphs were normalized to this value. Supplementary Data File 2 shows the exact MOI for each experiment. qPCR. Total DNA was extracted from S. aureus cells using a modified phenolchloroform-isoamyl alcohol (Fisher) protocol as described 35 . qPCR was performed using Fast SYBR Green Master Mix (Life Technologies) and 7900HT Fast Real-Time PCR System (Applied Biosystems) with primer pairs JW703/JW704 (φ 12) and W915/W916 (S. aureus RN4220 rho control). The sequences of the primers used in this study are listed in Supplementary Table 1 . Plaque formation assay. Plaque-forming units (p.f.u.) were counted on a layer of S. aureus cells suspended in 50% heart infusion agar (HIA) plated on a BHI agar base. Samples for measuring extracellular p.f.u. were obtained by filtering culture
Extended Data Figure 4 | Patterns of φ12γ3 spacer acquisition using conventional primers or wild-type cas9. a, Abundance (RPM φ12 ) of φ 12γ 3 sequences incorporated into the CRISPR array after overnight infection at an MOI of 10. CRISPR loci within a single sample were amplified using either enrichment primers (green) or conventional primers (orange). Insert: location of the conventional primers outside the CRISPR repeats. b, Individual spacers common to both data sets in a plotted with RPM φ12 values for enrichment primers on the y axis and conventional primers on the x axis. The diagonal dotted line indicates the identity line. c, Abundance (RPM φ12 ) of φ 12γ 3 sequences incorporated into the CRISPR array after a 30-min infection at an MOI of 100 of cells harbouring hcas9 (purple) or wild-type cas9 (green). d, Individual spacers common to both data sets in c were plotted with RPM φ12 values for hcas9 on the y axis and wild-type cas9 on the x axis. The diagonal dotted line indicates the identity line.
